PNC Financial Services Group
VRCA icon

PNC Financial Services Group’s Verrica Pharmaceuticals VRCA Stock Holding History

PNC Financial Services Group’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$540 Hold
102
– – ﹤0.01% 4896
2025
Q4 		$847 Hold
102
– – ﹤0.01% 4733
2025
Q3 		$439 Sell
102
-1
-1% -$6 ﹤0.01% 4826
2025
Q2 		$547 Sell
103
-328
-76% -$1.76K ﹤0.01% 4672
2025
Q1 		$1.91K Buy
431
+419
+3,492% +$2.71K ﹤0.01% 4360
2024
Q4 		$81 Sell
12
-35
-74% -$385 ﹤0.01% 4720
2024
Q3 		$677 Buy
47
+25
+114% +$1.13K ﹤0.01% 4522
2024
Q2 		$1.62K Hold
22
– – ﹤0.01% 4310
2024
Q1 		$1.31K Buy
22
+21
+2,100% +$1.16K ﹤0.01% 4305
2023
Q4 		$88 Buy
+1
New +$41 ﹤0.01% 4523

Other funds holding VRCA

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $154M AUM 40.62% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return